Selective and cytokine-dependent regulation of hepatic transporters and bile acid homeostasis during infectious colitis in mice

Drug Metabolism and Disposition

Volumn 42, Issue 4, 2014, Pages 596-602

  Merrell, Matthew D ^a   Nyagode, Beatrice A ^a   Clarke, John D ^b   Cherrington, Nathan J ^b   Morgan, Edward T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILE SALT EXPORT PUMP; BREAST CANCER RESISTANCE PROTEIN; CARNITINE TRANSPORTER 1; CARNITINE TRANSPORTER 2; CHOLESTEROL 7ALPHA MONOOXYGENASE; FARNESOID X RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 6; LIVER X RECEPTOR; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 6; MULTIDRUG RESISTANCE PROTEIN 3; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER B; ORGANIC ANION TRANSPORTER D; ORGANIC CATION TRANSPORTER 1; SODIUM BILE ACID COTRANSPORTER; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A1; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A4; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B2; TOLL LIKE RECEPTOR 4;

ABCB11 GENE; ABCB1A GENE; ABCB1B GENE; ABCB4 GENE; ABCC2 GENE; ABCC3 GENE; ABCC4 GENE; ABCC6 GENE; ABCG2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITROBACTER RODENTIUM; COLITIS; CONTROLLED STUDY; CYP7A1 GENE; DOWN REGULATION; ENTEROBACTERIACEAE INFECTION; FARNESOID X RECEPTOR GENE; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; HOMEOSTASIS; LIVER X RECEPTOR GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLC10A1 GENE; SLC22A1 GENE; SLC22A4 GENE; SLC22A5 GENE; SLC22A7 GENE; SLCO1A1 GENE; SLCO1A4 GENE; SLCO1B2 GENE; SLCO3A1 GENE;

ANIMALS; BILE ACIDS AND SALTS; CARRIER PROTEINS; CITROBACTER; COLITIS; CYTOKINES; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; LIVER; MICE; MICE, INBRED C3H; MICE, INBRED C57BL;

EID: 84896115462     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.055525     Document Type: Article

References (40)

1. Andrejko KM, Raj NR, Kim PK, Cereda M, and Deutschman CS (2008) IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters. Shock 29: 490-496. (Pubitemid 351416803)
2. Bodeman CE, Dzierlenga AL, Tally CM, Mulligan RM, Lake AD, Cherrington NJ, and McKarns SC (2013) Differential regulation of hepatic organic cation transporter 1, organic aniontransporting polypeptide 1a4, bile-salt export pump, and multidrug resistance-associated protein 2 transporter expression in lymphocyte-deficient mice associates with interleukin-6 production. J Pharmacol Exp Ther 347:136-144.
3. Chaluvadi MR, Kinloch RD, Nyagode BA, Richardson TA, Raynor MJ, Sherman M, Antonovic L, Strobel HW, Dillehay DL, and Morgan ET (2009) Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium. Drug Metab Dispos 37:366-374.
4. Cherrington NJ, Estrada TE, Frisk HA, Canet MJ, Hardwick RN, Dvorak B, Lux K, and Halpern MD (2013) The hepatic bile acid transporters Ntcp and Mrp2 are downregulated in experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 304:G48-G56.
5. Congiu M, Mashford ML, Slavin JL, and Desmond PV (2009) Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease. J Gastroenterol Hepatol 24:1038-1044.
6. Cressman AM, Petrovic V, and Piquette-Miller M (2012) Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response. Expert Rev Clin Pharmacol 5:69-89.
7. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, and Stewart TA (1993) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742. (Pubitemid 23114658)
8. Feingold KR, Spady DK, Pollock AS, Moser AH, and Grunfeld C (1996) Endotoxin, TNF, and IL-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. J Lipid Res 37: 223-228. (Pubitemid 26078941)
9. Fisher CD, Lickteig AJ, Augustine LM, Oude Elferink RP, Besselsen DG, Erickson RP, and Cherrington NJ (2009) Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats. Eur J Pharmacol 613:119-127.
10. Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, Lorenzen J, Matern S, and Gartung C (2003) Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38:345-354. (Pubitemid 36919855)
11. Geier A, Wagner M, Dietrich CG, and Trauner M (2007) Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta 1773:283-308. (Pubitemid 46275063)
12. Gong L, Aranibar N, Han YH, Zhang Y, Lecureux L, Bhaskaran V, Khandelwal P, Klaassen CD, and Lehman-McKeeman LD (2011) Characterization of organic anion-transporting polypeptide (Oatp) 1a1 and 1a4 null mice reveals altered transport function and urinary metabolomic profiles. Toxicological Sci 122:587-597.
13. Gu X and Manautou JE (2010) Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev 42:482-538.
14. Jahnel J, Fickert P, Langner C, Högenauer C, Silbert D, Gumhold J, Fuchsbichler A, and Trauner M (2009) Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice. Liver Int 29:1316-1325.
15. Janneh O, Chandler B, Hartkoorn R, Kwan WS, Jenkinson C, Evans S, Back DJ, Owen A, and Khoo SH (2009) Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes. J Antimicrob Chemother 64:1002-1007.
16. Keppler D (2011) Cholestasis and the role of basolateral efflux pumps. Z Gastroenterol 49: 1553-1557.
17. Kim MS, Shigenaga J, Moser A, Feingold K, and Grunfeld C (2003) Repression of farnesoid X receptor during the acute phase response. J Biol Chem 278:8988-8995. (Pubitemid 36800376)
18. Kinloch RD, Lee CM, van Rooijen N, and Morgan ET (2011) Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen. Biochem Pharmacol 82:312-321.
19. Klaassen CD and Aleksunes LM (2010) Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62:1-96.
20. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, and Köhler G (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342. (Pubitemid 24104268)
21. Le Vee M, Jouan E, Moreau A, and Fardel O (2011) Regulation of drug transporter mRNA expression by interferon-g in primary human hepatocytes. Fundam Clin Pharmacol 25:99-103.
22. Lickteig AJ, Slitt AL, Arkan MC, Karin M, and Cherrington NJ (2007) Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos 35:402-409. (Pubitemid 46333903)
23. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. (Pubitemid 34164012)
24. Moltó J, Xinarianos G, Miranda C, Pushpakom S, Cedeño S, Clotet B, Owen A, and Valle M (2013) Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients. Clin Pharmacokinet 52:543-553.
25. Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, Charles KA, Clarke SJ, Kacevska M, and Liddle C, et al. (2008) Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 36:205-216. (Pubitemid 351185732)
26. Nyagode BA, Lee CM, and Morgan ET (2010) Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-gamma-null mice. J Pharmacol Exp Ther 335:480-488.
27. Ohkura N, Shigetani Y, Yoshiba N, Yoshiba K, and Okiji T (2012) Gene expression analysis of membrane transport proteins in normal and lipopolysaccharide-inflamed rat dental pulp. J Endod 38:648-652.
28. Ose A, Kusuhara H, Endo C, Tohyama K, Miyajima M, Kitamura S, and Sugiyama Y (2010) Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier. Drug Metab Dispos 38:168-176.
29. Petrovic V, Wang JH, and Piquette-Miller M (2008) Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab Dispos 36: 1944-1950.
30. Richardson TA and Morgan ET (2005) Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. J Pharmacol Exp Ther 314:703-709. (Pubitemid 41043852)
31. Richardson TA, Sherman M, Antonovic L, Kardar SS, Strobel HW, Kalman D, and Morgan ET (2006) Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice. Drug Metab Dispos 34 : 354-360. (Pubitemid 43290892)
32. Ruiz ML, Rigalli JP, Arias A, Villanueva S, Banchio C, Vore M, Mottino AD, and Catania VA (2013) Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor. Drug Metab Dispos 41:275-280.
33. Saab L, Peluso J, Muller CD, and Ubeaud-Sequier G (2013) Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry. Cytometry Part A 83:403-408.
34. Sharma R, Kacevska M, London R, Clarke SJ, Liddle C, and Robertson G (2008) Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies. Br J Cancer 98:91-97.
35. Shitara Y, Maeda K, Ikejiri K, Yoshida K, Horie T, and Sugiyama Y (2013) Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. Biopharm Drug Dispos 34:45-78.
36. Siewert E, Dietrich CG, Lammert F, Heinrich PC, Matern S, Gartung C, and Geier A (2004) Interleukin-6 regulates hepatic transporters during acute-phase response. Biochem Biophys Res Commun 322:232-238. (Pubitemid 39093860)
37. Teng S and Piquette-Miller M (2005) The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312:841-848. (Pubitemid 40189587)
38. Teng S and Piquette-Miller M (2008) Regulation of transporters by nuclear hormone receptors: implications during inflammation. Mol Pharm 5:67-76. (Pubitemid 351300036)
39. Vallance BA, Deng W, Jacobson K, and Finlay BB (2003) Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 71: 3443-3453. (Pubitemid 36637573)
40. Wojtal KA, Eloranta JJ, Hruz P, Gutmann H, Drewe J, Staumann A, Beglinger C, Fried M, Kullak-Ublick GA, and Vavricka SR (2009) Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metab Dispos 37: 1871-1877.